Junfeng Han

发表

Pseudo receptor probes: A novel pseudo receptor-based QSAR method and application into studies on a new kind of selective vascular endothelial growth factor-2 receptor inhibitors

Yanrong Ren, Yongwen Chen, Z. Ruan, 2008 .

MHC class I chain-related molecules induced on monocytes by IFN-γ promote NK cell activation

Yuzhang Wu, Zhao Yang, Li Wang, 2008 .

A systematic study of Tupaia as a model for human acute hepatitis B infection

Yuzhang Wu, Junfeng Han, Jun Li, 2021, The Journal of veterinary medical science.

Identification of leukemia-associated antigens in chronic myeloid leukemia by proteomic analysis.

B. Ni, Yuzhang Wu, Yongwen Chen, 2005, Leukemia research.

Efficacy and safety of a nanoparticle therapeutic vaccine in patients with chronic hepatitis B: A randomized clinical trial

J. Niu, Yuzhang Wu, Yongping Chen, 2021, Hepatology.

Tumor-derived soluble MICs impair CD3(+)CD56(+) NKT-like cell cytotoxicity in cancer patients.

Z. Ruan, Hui-ming Wang, Junfeng Han, 2008, Immunology letters.

DNA Vaccine Against Tumor Endothelial Marker 8 Inhibits Tumor Angiogenesis and Growth

Yuzhang Wu, Zhao Yang, Yongwen Chen, 2009, Journal of immunotherapy.

Identification of a new HLA-A*0201-restricted cytotoxic T lymphocyte epitope from CML28

Z. Ruan, Hui-ming Wang, Junfeng Han, 2006, Cancer Immunology, Immunotherapy.

Improving the prediction of HLA class I-binding peptides using a supertype-based method.

Jintao Li, Li Wang, Yuzhang Wu, 2014, Journal of immunological methods.

An altered peptide ligand for naïve cytotoxic T lymphocyte epitope of TRP-2(180–188) enhanced immunogenicity

B. Ni, Yuzhang Wu, Hui-ming Wang, 2006, Cancer Immunology, Immunotherapy.

Tumor-derived soluble MICs impair CD3(+)CD56(+) NKT-like cell cytotoxicity in cancer patients.

Z. Ruan, Hui-ming Wang, Junfeng Han, 2008, Immunology letters.